Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

The Expert View: Glaxo, Barclays and Shanta Gold

Our daily roundup of the best analyst commentary on shares, also including SpeaceandPeople and Randall & Quilter.

If you'd like to receive news alerts on any of the stocks mentioned in The Expert View, click on the star icons below to add them to your favourites.
If you'd like to receive news alerts on any of the stocks mentioned in The Expert View, click on the star icons below to add them to your favourites.
Key stats
Market capitalisation£79,996m
No. of shares out4,859m
No. of shares floating4,789m
No. of common shareholdersnot stated
No. of employees99817
Trading volume (10 day avg.)9m
Profit before tax£5,436m
Earnings per share110.51p
Cashflow per share143.16p
Cash per share115.35p

*Correct as at 22 Apr 2014

GlaxoSmithKline’s Novartis deal wins upgrade from Panmure

Panmure Gordon analyst Savvas Neohpytou has upgraded his rating for GlaxoSmithKline (GSK.L) from ‘hold’ to ‘buy’ after the pharmaceutical giant struck a deal with rival Novartis to offload its oncology business.

The deal will see Glaxo swap its underperforming oncology arm for Novartis’ vaccines business, and launch a joint venture of both companies’ consumer businesses.

Nephoytou said the deal was a ‘sensible portfolio management’ step and retained his target price of £17.50. Shares closed yesterday up 84p, or 5.4%, at £16.43.

‘GlaxoSmithKline has underperformed in recent weeks, impacted mainly by missed upgrading opportunities from the pipeline and corruption allegations in the company’s Middle East and North Africa business,’ he said.

‘[The] transaction shows management will not sit idly by waiting for the pipeline to mature but will take brave decisions to unlock shareholder value.’

Key stats
Market capitalisation£14m
No. of shares out20m
No. of shares floating11m
No. of common shareholdersnot stated
No. of employees99
Trading volume (10 day avg.)0m
Profit before tax£2m
Earnings per share8.98p
Cashflow per share9.88p
Cash per share10.70p

*Correct as at 22 Apr 2014

SpaceandPeople severely downgraded after profit warning

Advertising broker SpaceandPeople (SAL.L) has been double downgraded following a profit warning.

Cantor analyst Sue Munden downgraded the AIM-listed company, which acts as a broker for advertising space in venues such as shopping centres, garden centres and retail parks, from ‘buy’ to ‘sell’ and the target price slashed from 170p to 72p. The shares were trading down 4.3% yesterday at 77p.

Munden’s downgrade comes after the company last week reported a 12% shortfall in revenue in the first quarter and that it expected profits to come in at half the expected level for the rest of the year.

‘The profit warning may well rattle investors and clearly the severity of the downgrade significantly reduces the profit and dividend prospects for the next two years leading to a sharp fall in our valuation,’ said Munden.

‘The question is whether this is a weakness caused by delays in sealing contracts and government approvals or does it herald a more fundamental flaw to the model. We still believe in the viability of the model… the business is pioneering in its delivery of [its] services and therefore teething problems will emerge.’

She added that ‘core businesses are experiencing problems at once’ and so a downgrade reflected the risks.

Key stats
Market capitalisation£40,595m
No. of shares out16,390m
No. of shares floating16,257m
No. of common shareholdersnot stated
No. of employees139600
Trading volume (10 day avg.)59m
Profit before tax£540m
Earnings per share3.68p
Cashflow per share16.53p
Cash per share283.54p

*Correct as at 22 Apr 2014

Barclays investment bank revamp could boost share price

A rescheduling of Barclays’ (BARC.L) first quarter interim management statement has led Shore Capital analysts to speculate on a revamp of its investment banking arm.

Analyst Gary Greenwood maintained a ‘buy’ recommendation on the shares, which were trading relatively flat at 245p yesterday.

The bank has pushed its first quarter statement to 6 May from 30 April and is also planning a ‘strategy day’ for 8 May which Greenwood said ‘is likely to involve a more serious revamping of the investment bank’. There are also rumours circulating that the bank is to wind down its commodities trading arm.

‘We would expect the outcome of any strategy update to result in lower revenue and profits in the investment bank being more than offset by lower capital consumption to allow for a higher future return on equity. With Barclays’ shares already trading on an undemanding multiple, a good presentation could therefore act as a positive catalyst for share price performance.’

Key stats
Market capitalisation£95m
No. of shares out72m
No. of shares floating43m
No. of common shareholdersnot stated
No. of employees362
Trading volume (10 day avg.)0m
Profit before tax£11m
Earnings per share22.12p
Cashflow per share33.80p
Cash per share105.27p

*Correct as at 22 Apr 2014

Randall & Quilter upgraded on attractive share valuation

Investment business Randall & Quilter (RQIH.L) has been upgraded by Numis on the back of strong full year 2013 figures that prove the company is ‘heading towards long-term value’.

Analyst Nick Johnson upgraded his recommendation from ‘hold’ to ‘buy’ and retained a target price of 165p. The shares were up 0.7% at 131p yesterday.

The company reported profits before tax of £9.6 million, in line with Numis’ £9.5 million forecast, and that the acquisition pipeline had ‘never been healthier’.

‘Randall & Quilter has maintained its record of superior investment earnings with a return of 3.7% in 2013, being materially better than most peers,’ added Johnson.

The analyst is backing the shares on the company’s long-term growth prospects. ‘We are encouraged that short-term earnings look to be underpinned by healthy run-off activity, pending longer-term growth from the live ventures. Having sold off in the early part of this year we think Randall & Quilter shares now look attractive value.’

Key stats
Market capitalisation£68m
No. of shares out462m
No. of shares floating385m
No. of common shareholdersnot stated
No. of employeesnot stated
Trading volume (10 day avg.)1m
Turnover0m USD
Profit before tax-9m USD
Earnings per share-0.03 USD
Cashflow per share-0.03 USD
Cash per share0.01 USD

*Correct as at 22 Apr 2014

Take advantage of Shanta Gold share price now, says Peel Hunt

Full year results from Tanzania miner Shanta Gold (SHAN.L) show the company is ‘well positioned for the future’, according to Peel Hunt analyst Maurice Mason.

Mason has retained a ‘buy’ recommendation and a target price of 20p on the shares, which were trading down marginally 0.8% at 14.5p yesterday.

He noted strong cash generation and operating cash flows that have ‘enabled the company to significantly strengthen the balance sheet on previous years with a restructured debt position’.

‘The company remains well positioned for 2014 as a number of initiatives implemented in 2013 and currently in progress are set to bear fruit,’ said Mason. ‘Investors have an opportunity to capitalise on these improvements before they are reflected in the current share price.’

Your Business: Cover Star Club

Profile: Thomas Miller explains its post-restructure plans

Profile: Thomas Miller explains its post-restructure plans

Thomas Miller Investment’s (TMI) head of wealth Matt Phillips has strong opinions about many things

Wealth Manager on Twitter